COMMUNIQUÉS West-GlobeNewswire

Selecta Biosciences to Present at the Jefferies Gene Therapy Summit on September 27, 2018

20/09/2018 - 14:00

WATERTOWN, Mass., Sept. 20, 2018 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (Nasdaq: SELB), a clinical-stage biopharmaceutical company focused on unlocking the full potential of biologic therapies by mitigating [...]

Iterum Therapeutics to Present Clinical Data on Antibiotic Sulopenem at IDWeek 2018

20/09/2018 - 14:00

DUBLIN, Ireland and CHICAGO, Sept. 20, 2018 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM), a clinical-stage pharmaceutical company developing antibiotics against multi-drug resistant pathogens, today [...]

Wave Life Sciences to Present New Data on Its DMD Exon 53 Skipping Program and Discovery Platform at Upcoming Meetings

20/09/2018 - 14:00

CAMBRIDGE, Mass., Sept. 20, 2018 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (NASDAQ: WVE), a biotechnology company focused on delivering transformational therapies for patients with serious, genetically-defined [...]

OncoMed Provides Update on Navicixizumab Partnership

20/09/2018 - 14:00

REDWOOD CITY, Calif., Sept. 20, 2018 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals Inc. (NASDAQ: OMED), a clinical-stage biopharmaceutical company focused on discovering and developing novel anti-cancer therapeutics, [...]

Tetra Bio-Pharma Announces Significant Progress on Storz & Bickel Co-Development in Treating Fibromyalgia

20/09/2018 - 14:00

ORLEANS, Ontario, Sept. 20, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc ., a leader in cannabinoid-based drug discovery and development (TSX VENTURE: TBP) (OTCQB: TBPMF), has made significant progress in its co- [...]

XBiotech Announces Addition of Top Dermatologist and Researcher Dr. Alice Gottlieb to its Team

20/09/2018 - 14:00

AUSTIN, Texas, Sept. 20, 2018 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) announced today the addition of Alice Gottlieb, M.D., Ph.D., to its Scientific Advisory Board (SAB). Dr. Alice Gottlieb is internationally [...]

Galectin Therapeutics, Inc. Announces Positive Preliminary Results from Phase 1b Clinical Trial of GR-MD-02 and KEYTRUDA® in Advanced Melanoma and Expansion of the Trial

20/09/2018 - 14:00

Combination immunotherapy of GR-MD-02 and KEYTRUDA for all cohorts reported shows an Objective Response Rate of 50% (seven of fourteen patients). The published response rate of KEYTRUDA alone is 33% in melanoma [...]

Maverick Technology Solutions Receives Approval for Name Change and Symbol Change

20/09/2018 - 14:00

Concludes Final Step of Its Merger RENO, Nev., Sept. 20, 2018 (GLOBE NEWSWIRE) -- Maverick Technology Solutions, developer and manufacturer of the ROSINBOMB brand of industry leading consumer and commercial rosin [...]

Cocrystal Pharma Completes Patient Enrollment in Phase 2a Study Evaluating CC-31244 for Ultra-Short Treatment of Hepatitis C

20/09/2018 - 14:00

ATLANTA, GA and BOTHELL, WA, Sept. 20, 2018 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (NASDAQ: COCP), (“Cocrystal” or the “Company”), a clinical stage biotechnology company discovering and developing novel antiviral [...]

Tabula Rasa HealthCare Brings Together PACE Medical Directors at 2018 Clinical Advisory Panel Meeting

20/09/2018 - 14:00

TRHC Clinical Pharmacists and PACE Medical Directors Gather to Learn MOORESTOWN, N.J., Sept. 20, 2018 (GLOBE NEWSWIRE) -- CareKinesis, a subsidiary of Tabula Rasa HealthCare (NASDAQ:TRHC), is hosting its 12 th Clinical [...]

Avalon GloboCare Commences Operation of its Core GMP Platform, Epicon Biotech, to Facilitate Clinical Development of Cellular Therapies

20/09/2018 - 14:00

FREEHOLD, N.J., Sept. 20, 2018 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (OTCQB: AVCO), a leading global developer of cell-based technologies, announced today that the Company has officially commenced operation of [...]

Precipio Expands ICE-COLD PCR™ Lung Cancer Mutation Detection Offering

20/09/2018 - 13:37

New kit examines most relevant EGFR exons that impact therapeutic decisions for lung cancer patients NEW HAVEN, Conn., Sept. 20, 2018 (GLOBE NEWSWIRE) -- Precipio, Inc. ( NASDAQ: PRPO ), announced today the launch of a [...]

Integrated Cannabis Company, Inc. Signs Distribution Agreement with Empower Clinics, Inc.

20/09/2018 - 13:30

VANCOUVER, British Columbia, Sept. 20, 2018 (GLOBE NEWSWIRE) -- Integrated Cannabis Company, Inc. (CSE: ICAN, OTCQB: ICNAF) (“ Integrated Cannabis ”), is pleased to announce the completion of a Letter of Intent (LOI) to [...]

Conatus Pharmaceuticals to Host Analyst and Investor Symposium on Portal Hypertension

20/09/2018 - 13:30

SAN DIEGO, Sept. 20, 2018 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq:CNAT), a biotechnology company focused on the development of novel medicines to treat liver disease, will host an invitation-only [...]

FDA Accepts Asterias Biotherapeutics’ Request to Meet and Discuss Next Phase of Development for OPC1 Spinal Cord Injury Clinical Program

20/09/2018 - 13:00

FREMONT, Calif., Sept. 20, 2018 (GLOBE NEWSWIRE) -- Asterias Biotherapeutics, Inc. (NYSE American: AST), a biotechnology company dedicated to developing cell-based therapeutics to treat neurological conditions [...]

Axovant to Present at Two Upcoming Investor Conferences

20/09/2018 - 13:00

BASEL, Switzerland, Sept. 20, 2018 (GLOBE NEWSWIRE) -- Axovant Sciences (NASDAQ:AXON) today announced that Pavan Cheruvu, M.D., chief executive officer, will present a corporate overview at the Jefferies Gene Therapy [...]

Aleafia Partners With Cronos Group on Medical Cannabis Sleep Study

20/09/2018 - 13:00

TORONTO, Sept. 20, 2018 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSXV: ALEF; OTCQX: ALEAF, FRA: ARAH) (“Aleafia“) and Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group”) are pleased to announce the [...]

Summit Reports Financial Results for the Second Quarter Ended 31 July 2018 and Operational Progress

20/09/2018 - 13:00

Summit Therapeutics plc (‘Summit’, the ‘Company’ or the ‘Group’) Summit Therapeutics Reports Financial Results for the Second Quarter and Half Year Ended 31 July 2018 and Operational Progress Oxford, UK, and Cambridge, [...]

Health Canada has authorized TAKHZYRO(TM) (lanadelumab injection), a first-of-its-kind monoclonal antibody treatment for the prevention of hereditary angioedema (HAE) attacks

20/09/2018 - 13:00

Health Canada has authorized TAKHZYRO TM (lanadelumab injection), a first-of-its-kind monoclonal antibody treatment for the prevention of hereditary angioedema (HAE) attacks New treatment option for HAE receives first [...]